tradingkey.logo
搜索

Zimmer Biomet Holdings Inc

ZBH
添加自选
93.930USD
-1.020-1.07%
收盘 07-31 16:00美东报价延迟15分钟
18.17B总市值
24.29市盈率 TTM

关于 Zimmer Biomet Holdings Inc 公司

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.

Zimmer Biomet Holdings Inc简介

公司代码ZBH
公司名称Zimmer Biomet Holdings Inc
上市日期Jul 25, 2001
CEOTornos (Ivan)
员工数量17000
证券类型Ordinary Share
年结日Jul 25
公司地址345 E Main St
城市WARSAW
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编46580-2746
电话15742676131
网址https://www.zimmerbiomet.com/en
公司代码ZBH
上市日期Jul 25, 2001
CEOTornos (Ivan)

Zimmer Biomet Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
83.19K
+18.64%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
69.48K
+11.80%
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
66.30K
+6.11%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
27.00K
-18.52%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.19K
+7.91%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
5.23K
+20.18%
Mr. Jehanzeb Noor
Mr. Jehanzeb Noor
Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Senior Vice President, Chief Strategy, Innovation and Business Development Officer
5.15K
+96.08%
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
83.19K
+18.64%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
69.48K
+11.80%
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
66.30K
+6.11%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
27.00K
-18.52%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.19K
+7.91%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--

常见问题

Zimmer Biomet Holdings Inc的前五大股东是谁?

Zimmer Biomet Holdings Inc 的前五大股东如下:Mr. Ivan Tornos

哪个业务部门对Zimmer Biomet Holdings Inc的收入贡献最大?

在2026Q4,Knees业务部门对Zimmer Biomet Holdings Inc的收入贡献最大,创收3.32B,占总收入的40.36%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有